Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

ADVM holding history

Adverum Biotechnologies, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADVM overviewAll 13F holders of ADVMFull Q4 2025 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of ADVM by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−872,041−100.0%Sold outHolders
Q3 2025872,041$3.95M<0.1%−11,896−1.3%ReducedHolders
Q2 2025883,937$1.90M<0.1%−145,389−14.1%ReducedHolders
Q1 20251,029,326$4.50M<0.1%−1,756−0.2%ReducedHolders
Q4 20241,031,082$4.82M<0.1%+3,428+0.3%AddedHolders
Q3 20241,027,654$7.21M<0.1%+18,195+1.8%AddedHolders
Q2 20241,009,459$6.92M<0.1%+102,308+11.3%AddedHolders
Q1 2024907,151$12.8M<0.1%+488,248+116.6%AddedConverted for a 1-for-10 splitHolders
Q4 20234,189,034$3.15M<0.1%00.0%UnchangedHolders
Q3 20234,189,034$6.28M<0.1%+127,000+3.1%AddedHolders
Q2 20234,062,034$6.46M<0.1%−81,097−2.0%ReducedHolders
Q1 20234,143,131$2.97M<0.1%+140,100+3.5%AddedHolders
Q4 20224,003,031$2.32M<0.1%+1,8260.0%AddedHolders
Q3 20224,001,205$3.80M<0.1%−156,400−3.8%ReducedHolders
Q2 20224,157,605$4.99M<0.1%+621,241+17.6%AddedHolders
Q1 20223,536,364$4.63M<0.1%−708,586−16.7%ReducedHolders
Q4 20214,244,950$7.47M<0.1%−133,809−3.1%ReducedHolders
Q3 20214,378,759$9.50M<0.1%+32,988+0.8%AddedHolders
Q2 20214,345,771$15.2M<0.1%−238,269−5.2%ReducedHolders
Q1 20214,584,040$45.2M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.